Members of the coronaviridae family are endemic to human populations and have caused
several epidemics and pandemics in recent history. In this review, we will discuss the …

SARS-CoV-2 infections manifest with a broad spectrum of presentations, ranging from
asymptomatic infections to severe pneumonia and fatal outcomes. This review centers on …

Ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has
given rise to recombinant Omicron lineages that dominate globally (XBB. 1), as well as the …

T cells are critical in mediating the early control of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether …

The paucity of information on longevity of vaccine-induced immune responses and
uncertainty of the correlates of protection hinder the development of evidence-based COVID …

The spike glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
continues to accumulate substitutions, leading to breakthrough infections of vaccinated …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
prompted scientific, medical, and biotech communities to investigate infection-and vaccine …

The SARS-CoV-2 Omicron sub-variants BA. 2.86 and JN. 1 contain multiple mutations in the
spike protein that were not present in previous variants of concern and Omicron sub …

The receptor-binding domain (RBD) of the SARS-CoV-2 spike is a primary target of
neutralizing antibodies and a key component of licensed vaccines. Substantial mutations in …

Little is known about the effect of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2 or SARS2) vaccine breakthrough infections (BTIs) on the magnitude and breadth of …